Learn More
Medchemexpress LLC Menin-MLL inhibitor 19 | 2360487-93-8 | 98.1% | 645.70 | 50 MG

Supplier: Medchemexpress LLC HY13907650MG
Menin-MLL inhibitor 19 is a potent exo-aza spiro inhibitor of menin-mll interaction, identified as example A17 from patent WO2019120209A1. This compound is intended for research use only and can be utilized in the research of various diseases, including cancer, myelodysplastic syndrome (MDS), and diabetes.
- Potent exo-aza spiro inhibitor
- Used for cancer research
- Used for myelodysplastic syndrome (MDS) research
- Used for diabetes research
- Solid appearance
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.